1221. Non-severe, non-immune mediated intolerances: simple targets for direct non-invasive delabeling opportunities of beta-lactam antibiotic allergy labels (BAAL)

BACKGROUND: Majority of patients with a BAALs can tolerate a β-lactam without concerns for a severe IgE-mediated reaction. Many BAALs are confirmed to be intolerances or adverse events versus a true allergy. False BAALs can result in the use of alternative non-BLs, posing risk for collateral health...

Descripción completa

Detalles Bibliográficos
Autores principales: Polisetty, Radhika S, Dickens, Michael, Tran, Hoang, Khankan, Nour, Weslander, Erin, Bertram, Christie M, Moore, William J, Wang, Sheila K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678977/
http://dx.doi.org/10.1093/ofid/ofad500.1061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678977/
http://dx.doi.org/10.1093/ofid/ofad500.1061

Ejemplares similares